Pediatric glioma histone H3.3 K27M/G34R mutations drive abnormalities in PML nuclear bodies
Abstract Background Point mutations in histone variant H3.3 (H3.3K27M, H3.3G34R) and the H3.3-specific ATRX/DAXX chaperone complex are frequent events in pediatric gliomas. These H3.3 point mutations affect many chromatin modifications but the exact oncogenic mechanisms are currently unclear. Histon...
Main Authors: | Hsiao P. J. Voon, Linda Hii, Andrew Garvie, Maheshi Udugama, Brian Krug, Caterina Russo, Anderly C. Chüeh, Roger J. Daly, Alison Morey, Toby D. M. Bell, Stephen J. Turner, Joseph Rosenbluh, Paul Daniel, Ron Firestein, Jeffrey R. Mann, Philippe Collas, Nada Jabado, Lee H. Wong |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-12-01
|
Series: | Genome Biology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s13059-023-03122-5 |
Similar Items
-
Interplay between PML NBs and HIRA for H3.3 dynamics following type I interferon stimulus
by: Constance Kleijwegt, et al.
Published: (2023-05-01) -
A phase II study evaluating the role of bortezomib in the management of relapsed acute promyelocytic leukemia treated upfront with arsenic trioxide
by: Uday Kulkarni, et al.
Published: (2020-04-01) -
Recent advances in the diagnosis and management of childhood acute promyelocytic leukemia
by: Eun Sun Yoo
Published: (2011-03-01) -
Assessment Synergistic Effects of Integrated Therapy with Epigallocatechin-3-Gallate (EGCG) & Arsenic Trioxide and Irradiation on Breast Cancer Cell Line
by: Vahid CHANGIZI, et al.
Published: (2020-07-01) -
PML-RARA mutations confer varying arsenic trioxide resistance
by: Dong-Mei Bai, et al.
Published: (2016-12-01)